Investment Trusts
The latest news, updates and opinions on Investment Trusts from the expert team here at MoneyWeek

-
The most popular UK small caps among investment trust managers
While unloved by some areas of the market, UK small caps have a deserved following among investment trust managers. Four companies in particular stand out among the sector’s experts.
By Dan McEvoy Published
-
The investment trust sectors driving UK outperformance
UK-focused investment trusts have gained while global counterparts have flatlined during a turbulent few months. Which sectors have driven this resilience in the face of tariff disruption?
By Dan McEvoy Published
-
Which investment trusts could benefit from lower interest rates?
As vehicles for long-term investments, many investment trusts were hit when interest rates rose in 2022. With interest rates expected to fall by the end of the year, could now be the time to invest in one of these unloved sectors?
By Dan McEvoy Published
-
Seven technology investment trusts to consider
Buying a technology investment trust is a great way to gain exposure to long-term growth trends, but be wary of Magnificent Seven over-concentration
By Dan McEvoy Published
-
Tap into investment trusts to profit from private equity
Opinion The investment companies providing access to unlisted firms’ robust growth are looking cheap, says Max King
By Max King Published
Opinion -
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
By Peter Walls Published
Opinion -
Best-performing funds and investment trusts for stocks and shares ISAs of all time
As ISAs celebrate their 26th birthday, we reveal the best-performing funds and investment trusts since stocks and shares ISAs launched in April 1999, and how much they would be worth today
By Ruth Emery Published
-
Two top Asia-focused investment trusts
Pacific Assets and Scottish Oriental are both trusts that focus on high-quality companies controlled by trustworthy families or founders
By Max King Published
-
Cash in on the biotech sector with specialist BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
Opinion